...
首页> 外文期刊>Chromatographia >Characterization of Interactions Between Fluoroquinolones and Human Serum Albumin by CE–Frontal Analysis
【24h】

Characterization of Interactions Between Fluoroquinolones and Human Serum Albumin by CE–Frontal Analysis

机译:CE额叶分析表征氟喹诺酮类药物与人血清白蛋白之间的相互作用

获取原文
获取原文并翻译 | 示例
           

摘要

The binding of fluoroquinolones to the transport protein, human serum albumin (HSA), under simulated physiological conditions has been studied by capillary electrophoresis–frontal analysis (CE–FA). The binding of these drugs to human plasma was evaluated by using ultrafiltration and capillary electrophoresis. The free drug concentration [D]f at each HSA concentration was determined by the plateau height in the electropherograms and the calibration lines. The binding constants of fluoroquinolones and HSA were estimated using nonlinear regression with origin 7.5 software. The fluoroquinolones were found to show low affinity toward HSA, with binding constants ranging from 1.73 × 102 to 5.40 × 102 M−1. The percentages of protein binding (PB) for fluoroquinolones to HSA were between 8.6 and 22.2%, while the PB percentages for fluoroquinolones to human plasma were between 10.2 and 33.1%. It can be found that the PB percentages for fluoroquinolones to HSA are mostly lower than those for fluoroquinolones to human plasma. It suggests that HSA is the primary protein responsible for the binding of fluoroquinolones in human plasma. The thermodynamic parameters were obtained by CE–FA. The positive ∆H and ∆S values obtained by CE–FA showed that the binding reaction was an endothermic process, and the entropy drive the binding and hydrophobic interaction played major roles in the binding of fluoroquinolones to HSA.
机译:氟喹诺酮类药物在模拟生理条件下与转运蛋白人血清白蛋白(HSA)的结合已通过毛细管电泳-额叶分析(CE-FA)进行了研究。通过使用超滤和毛细管电泳评估了这些药物与人血浆的结合。每种HSA浓度下的游离药物浓度[D] 由电泳图和校正线上的平台高度确定。使用Origin 7.5软件使用非线性回归估计氟喹诺酮类和HSA的结合常数。发现氟喹诺酮类药物对HSA的亲和力低,结合常数范围为1.73×10 2 至5.40×10 2 M -1 。氟喹诺酮类与HSA的蛋白质结合(PB)百分比介于8.6和22.2%之间,而氟喹诺酮类与人血浆的PB百分比介于10.2和33.1%之间。可以发现,氟喹诺酮类药物相对于HSA的PB百分比大多低于氟喹诺酮类药物相对于人血浆的PB百分比。这表明HSA是负责人血浆中氟喹诺酮类结合的主要蛋白质。热力学参数是通过CE–FA获得的。 CE-FA获得的正ΔH和ΔS值表明,结合反应是吸热过程,并且熵驱动结合和疏水相互作用在氟喹诺酮类化合物与HSA的结合中起主要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号